Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody–Positive Patients Without Rheumatoid Arthritis

To investigate the risk of progression to rheumatoid arthritis (RA) in patients who were cyclic citrullinated peptide (CCP) antibody positive without RA at initial presentation.

[1]  R. Green,et al.  Effectiveness of a Web‐Based Personalized Rheumatoid Arthritis Risk Tool With or Without a Health Educator for Knowledge of Rheumatoid Arthritis Risk Factors , 2018, Arthritis care & research.

[2]  Xp Li,et al.  FRI0255 Injection of cd40 dna vaccine ameliorates the autoimmune pathology of non-obese diabetic mice with sjogren’s syndrome , 2018, FRIDAY, 15 JUNE 2018.

[3]  R. Green,et al.  Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial , 2018, Arthritis care & research.

[4]  P. Verschueren,et al.  Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis , 2018, Annals of the rheumatic diseases.

[5]  C. Allaart,et al.  Brief Report: Clinical Trials Aiming to Prevent Rheumatoid Arthritis Cannot Detect Prevention Without Adequate Risk Stratification: A Trial of Methotrexate Versus Placebo in Undifferentiated Arthritis as an Example , 2017, Arthritis & rheumatology.

[6]  P. Gregersen,et al.  Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis , 2016, Annals of the rheumatic diseases.

[7]  C. Allaart,et al.  Clinical trials aiming to prevent Rheumatoid Arthritis cannot detect prevention without adequate risk stratification; the PROMPT‐trial as example , 2017 .

[8]  L. Trouw,et al.  Role of Anti–Carbamylated Protein Antibodies Compared to Anti–Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First‐Degree Relatives, and Healthy Controls , 2016, Arthritis & rheumatology.

[9]  T. Huizinga,et al.  Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis, First-Degree Relatives and Controls: Comparison to Anti-Citrullinated Protein Antibodies- Reply to letter to the editor from Hutchinson and colleagues. , 2016 .

[10]  S. Saevarsdottir,et al.  Family history of rheumatoid arthritis: an old concept with new developments , 2016, Nature Reviews Rheumatology.

[11]  P. Gregersen,et al.  Associations of Smoking and Age With Inflammatory Joint Signs Among Unaffected First‐Degree Relatives of Rheumatoid Arthritis Patients: Results From Studies of the Etiology of Rheumatoid Arthritis , 2016, Arthritis & rheumatology.

[12]  J. Castillo-Ortiz,et al.  Autoantibodies in Prediction of the Development of Rheumatoid Arthritis Among Healthy Relatives of Patients With the Disease , 2015, Arthritis & rheumatology.

[13]  R. Zhong,et al.  Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis , 2015, Arthritis Research & Therapy.

[14]  E. Karlson,et al.  To What Extent Is the Familial Risk of Rheumatoid Arthritis Explained by Established Rheumatoid Arthritis Risk Factors? , 2015, Arthritis & rheumatology.

[15]  P. Emery,et al.  Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study , 2014, Annals of the rheumatic diseases.

[16]  Chia-Yen Chen,et al.  Contributions of Familial Rheumatoid Arthritis or Lupus and Environmental Factors to Risk of Rheumatoid Arthritis in Women: A Prospective Cohort Study , 2014, Arthritis care & research.

[17]  Chia-Yen Chen,et al.  Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study , 2014, Annals of the rheumatic diseases.

[18]  F. Grodstein,et al.  Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case–control study , 2013, Arthritis Research & Therapy.

[19]  Roger B. Davis,et al.  Clinical use of anti-cyclic citrullinated peptide antibody testing. , 2013, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[20]  P. Gregersen,et al.  Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease. , 2013, Arthritis and rheumatism.

[21]  K. Deane.  Can rheumatoid arthritis be prevented? , 2013, Best practice & research. Clinical rheumatology.

[22]  P. Gregersen,et al.  Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. , 2013, Arthritis and rheumatism.

[23]  V. Bini,et al.  Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study , 2013, Arthritis Research & Therapy.

[24]  D. van Schaardenburg,et al.  A prediction rule for the development of arthritis in seropositive arthralgia patients , 2012, Annals of the rheumatic diseases.

[25]  D. van Schaardenburg,et al.  Smoking and overweight determine the likelihood of developing rheumatoid arthritis , 2012, Annals of the rheumatic diseases.

[26]  P. Gregersen,et al.  Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA) , 2012, Annals of the rheumatic diseases.

[27]  R. Tibshirani,et al.  Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis , 2012, PloS one.

[28]  F. Tubach,et al.  High Levels of Anti-Cyclic Citrullinated Peptide Autoantibodies Are Associated with Co-occurrence of Pulmonary Diseases with Rheumatoid Arthritis , 2011, The Journal of Rheumatology.

[29]  T. Therneau,et al.  The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. , 2011, Arthritis and rheumatism.

[30]  Göran Hallmans,et al.  Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis , 2011, Arthritis research & therapy.

[31]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[32]  B. Dijkmans,et al.  Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study , 2009, Annals of the rheumatic diseases.

[33]  E. Karlson,et al.  Gene–environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis , 2009, Annals of the rheumatic diseases.

[34]  L. Alfredsson,et al.  Dietary Fish and Fish Oil and the Risk of Rheumatoid Arthritis , 2009, Epidemiology.

[35]  E. Karlson,et al.  Comparison of Threshold Cutpoints and Continuous Measures of Anti-Cyclic Citrullinated Peptide Antibodies in Predicting Future Rheumatoid Arthritis , 2009, The Journal of Rheumatology.

[36]  K. Hemminki,et al.  Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. , 2009, Arthritis and rheumatism.

[37]  L. Klareskog,et al.  Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells , 2008, Annals of the rheumatic diseases.

[38]  T. McAlindon,et al.  Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. , 2008, The Journal of rheumatology.

[39]  M. Dougados,et al.  Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review , 2005, Annals of the rheumatic diseases.

[40]  A. A. Drosos,et al.  Epidemiology of rheumatoid arthritis. , 2004, Autoimmunity reviews.

[41]  F. Breedveld,et al.  Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. , 2004, Arthritis and rheumatism.

[42]  B. Dijkmans,et al.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.

[43]  Göran Hallmans,et al.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[44]  M. Suarez‐Almazor,et al.  Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. , 2000, The Journal of rheumatology.

[45]  S. Gabriel,et al.  The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. , 1999, Arthritis and rheumatism.

[46]  T. Koepsell,et al.  Diet and Rheumatoid Arthritis in Women: A Possible Protective Effect of Fish Consumption , 1996, Epidemiology.

[47]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.